Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis

Atrial Fibrillation Begets Atrial Fibrillation

WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

Hansson, L., Lindholm, L. H., NISKANEN, L. K., Lanke, J., Hedner, T., Niklason, A., LUOMANMÄKI, K., Dahlöf, B., Fairé, U. D., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 1,991

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

Hansson, L., Lindholm, L. H., Ekbom, T., Dahlöf, B., Lanke, J., Scherstén, B., Wester, P.-O., Hedner, T., & Fairé, U. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)10327-1 · Cited by 1,442

The Study on Cognition and Prognosis in the Elderly (SCOPE)

Lithell, H., Hansson, L., Skoog, I. G., Elmfeldt, D., Albert Hofman, D., Olofsson, B., Trenkwalder, P., & Zanchetti, A. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00011 · Cited by 1,419

Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation

Frustaci, A., Chimenti, C., Bellocci, F., Morgante, E., Russo, M. A., & Maseri, A. (1997) · Circulation · doi:10.1161/01.cir.96.4.1180 · Cited by 1,400

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary

Fuster, V., Rydén, L., ASINGER, R. W., Cannom, D. S., Crijns, H. J. G. M., Frye, R. L., Halperin, J. L., Kay, G. N., Klein, W. W., Lévy, S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01587-x · Cited by 1,362

Promotion of Atrial Fibrillation by Heart Failure in Dogs

Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343

GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction

GRUPPOITALIANOPERLOSTUDIODELL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90232-1 · Cited by 1,201

Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol

Wachtell, K., Lehto, M., Gerdts, E., Olsen, M. H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen, S. E., Lindholm, L. H., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.10.068 · Cited by 826

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,954

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · EP Europace · doi:10.1093/europace/euq350 · Cited by 1,764

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.021 · Cited by 581

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Savelieva, I., Kakouros, N., Kourliouros, A., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/eur002 · Cited by 315

New antiarrhythmic drugs for treatment of atrial fibrillation

Dobrev, D., & Nattel, S. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60096-7 · Cited by 284

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Khan, N. A., Hemmelgarn, B. R., Padwal, R. S., Larochelle, P. M., Mahon, J. L., Lewanczuk, R. Z., McAlister, F. A., Rabkin, S. W., Hill, M. D., Feldman, R. D., et al. (2007) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(07)70798-5 · Cited by 109

2020 Clinical guidelines for Atrial fibrillation and atrial flutter

Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 258

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Khan, N. A., Hemmelgarn, B. R., Herman, R. J., Rabkin, S. W., McAlister, F. A., Bell, C. M., Touyz, R. M., Padwal, R. S., Leiter, L. A., Mahon, J. L., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70620-2 · Cited by 220

Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension

Manolis, A. J., Rosei, E. A., Coca, A., Cifkova, R., Erdine, S. E., Kjeldsen, S., Lip, G. Y. H., Narkiewicz, K., Parati, G., Redon, J., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834f03bf · Cited by 198

Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections

Stefansdottir, H., Aspelund, T., Gudnason, V. G., & Arnar, D. O. (2011) · EP Europace · doi:10.1093/europace/eur132 · Cited by 187

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Savelieva, I., Kakouros, N., Kourliouros, A., & Camm, A. J. (2011) · EP Europace · doi:10.1093/europace/eur023 · Cited by 160

Effects of Angiotensin-Converting Enzyme Inhibitor Therapy on Clinical Outcome in Patients Undergoing Coronary Artery Bypass Grafting

Miceli, A., Capoun, R., Fino, C., Narayan, P., Bryan, A. J., Angelini, G. D., & Caputo, M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.008 · Cited by 153

2018 Korean Guideline of Atrial Fibrillation Management

Joung, B., Lee, J., Lee, K. H., Kim, T., Choi, E., Lim, W., Kang, K., Uhm, J., Lim, H. E., Park, J., et al. (2018) · Korean Circulation Journal · doi:10.4070/kcj.2018.0339 · Cited by 157

Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies

Menezes, A. R., Lavie, C. J., DiNicolantonio, J. J., O’Keefe, J. H., Morin, D. P., Khatib, S., & Milani, R. V. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.01.022 · Cited by 141

Atrial fibrosis and atrial fibrillation: The role of the TGF-β1 signaling pathway

Gramley, F., Lorenzen, J., Koellensperger, E., Kettering, K., Weiß, C. H., & Münzel, T. F. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.03.110 · Cited by 127

n-3 Polyunsaturated Fatty Acids in the Prevention of Atrial Fibrillation Recurrences After Electrical Cardioversion

Nodari, S., Triggiani, M., Campia, U., Manerba, A., Milesi, G., Cesana, B. M., Gheorghiade, M., & Cas, L. D. (2011) · Circulation · doi:10.1161/circulationaha.111.022194 · Cited by 111

Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies

Crandall, M. A., Bradley, D. J., Packer, D. L., & Asirvatham, S. J. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.7.643 · Cited by 79

Atrial Fibrillation and Hypertension: Mechanistic, Epidemiologic, and Treatment Parallels

Ogunsua, A., Shaikh, A. Y., Ahmed, M., & McManus, D. D. (2015) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-11-4-228 · Cited by 80

Prevention of Atrial Fibrillation in High-risk Patients Undergoing Lung Cancer Surgery

Cardinale, D. M., Sandri, M. T., Colombo, A., Salvatici, M., Tedeschi, I., Bacchiani, G., Beggiato, M., Meroni, C. A., Civelli, M., Lamantia, G., et al. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001626 · Cited by 70

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000018 · Cited by 62

2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter

Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.521 · Cited by 58

Effects of angiotensin II receptor blockers on dementia

Mogi, M., & Horiuchi, M. (2009) · Hypertension Research · doi:10.1038/hr.2009.110 · Cited by 54

Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction — A meta analysis of 7 prospective clinical studies

Fu, M., Zhou, J., Sun, A., Zhang, S., Zhang, C., Zou, Y., Fu, M. L. X., & Ge, J. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.081 · Cited by 54

Role of Angiotensin‐Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Aldosterone Antagonists in the Prevention of Atrial and Ventricular Arrhythmias

Makkar, K. M., Sanoski, C. A., & Spinler, S. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.1.31 · Cited by 53

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis

Huang, G., Xu, J., Liu, J., He, Y., Nie, X.-L., Li, Q., Hu, Y., Zhao, S.-Q., Wang, M., Zhang, W., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02460.x · Cited by 52

Antiarrhythmic therapy in atrial fibrillation

Ravens, U. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.004 · Cited by 48

The programmed aging paradigm: How we get old

Libertini, G. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914100034 · Cited by 48

Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice

Suo, Y., Yuan, M., Li, H., Zhang, Y., Li, Y., Fu, H., Han, F., Ma, C., Wang, Y., Bao, Q., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01285 · Cited by 46

The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females

Patel, D., Mohanty, P. K., Biase, L. D., Wang, Y., Shaheen, M., Sanchez, J. E., Horton, R., Gallinghouse, G., ZAGRODZKY, J. D., Bailey, S., et al. (2010) · EP Europace · doi:10.1093/europace/eup387 · Cited by 45

The Role of Renin–Angiotensin System Blockade Therapy in the Prevention of Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Zhang, Y., Zhang, P., Mu, Y., Gao, M., WANG, J., Wang, Y., Su, L., & Hou, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.123 · Cited by 45

Outcomes of Preoperative Angiotensin-Converting Enzyme Inhibitor Therapy in Patients Undergoing Isolated Coronary Artery Bypass Grafting

Bandeali, S. J., Kayani, W. T., Lee, V., Pan, W., Elayda, M. A. A., Nambi, V., Jneid, H. M., Alam, M., Wilson, J. M., Birnbaum, Y., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.021 · Cited by 39

Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials

Zhao, D., Wang, Z., & Wang, L. (2015) · Journal of Biomedical Research · doi:10.7555/jbr.29.20140149 · Cited by 38

The Role Of Renin Angiotensin System In Atrial Fibrillation.

Nair, G. M., Nery, P. B., Redpath, C. J., & Birnie, D. H. (2014) · PubMed Central · doi:10.4022/jafib.972 · Cited by 38

2025 Clinical practice guidelines for Atrial fibrillation and flutter

Golukhova, E. Z., Sp, G., Михайлов, Е. Н., Revishvili, A. S. H., Arakelyan, M. G., Vasilyeva, E. Y., Davtyan, K. V., Drapkina, O. M., Drozdova, L. Y., Станиславовна, К. Е., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2025-6668 · Cited by 44

Virtual Screening Targeting the Urokinase Receptor, Biochemical and Cell-Based Studies, Synthesis, Pharmacokinetic Characterization, and Effect on Breast Tumor Metastasis

Wang, F., Li, J., Sinn, A. L., Knabe, W. E., Khanna, M., Jo, I., Silver, J. M., Oh, K., Li, L., Sandusky, G. E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200782y · Cited by 35

Assessment of atrial fibrosis for the rhythm control of atrial fibrillation

Begg, G. A., Holden, A. V., Lip, G. Y. H., Plein, S., & Tayebjee, M. H. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.144 · Cited by 33

Elevations in serum creatinine with RAAS blockade: why isnʼt it a sign of kidney injury?

Ryan, M. J., & Tuttle, K. R. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32830a9606 · Cited by 30

Telmisartan reduces atrial arrhythmia susceptibility through the regulation of RAS–ERK and PI3K–Akt–eNOS pathways in spontaneously hypertensive rats

Wang, W., Zhang, F., Chen, J., Chen, X., Fu, F., Tang, M., & Chen, L. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0416 · Cited by 31

Atrial fibrillation and inflammation

Özaydın, M. (2010) · World Journal of Cardiology · doi:10.4330/wjc.v2.i8.243 · Cited by 29

Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension

Akioyamen, L. E., Levine, M., Sherifali, D., O’Reilly, D. J., Frankfurter, C., Pullenayegum, E., Goeree, R. A., & Tsoi, B. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.11.005 · Cited by 28

Incidence, Management, Prevention and Outcome of Post-Operative Atrial Fibrillation in Thoracic Surgical Oncology

Fabiani, I., Colombo, A., Bacchiani, G., Cipolla, C. M., & Cardinale, D. M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010037 · Cited by 26

Cardiometabolic Risk Factors and Atrial Fibrillation

Menezes, A. R., Lavie, C. J., DiNicolantonio, J. J., O’Keefe, J. H., Morin, D. P., Khatib, S., Messerli, F. H., & Milani, R. V. (2013) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0693 · Cited by 25

Renin–angiotensin–aldosterone blockade reduces atrial fibrillation in hypertrophic cardiomyopathy

Huang, C., Yang, Y., Lin, L., Tsai, C., Hwang, J., Chen, P., & Lin, J.-L. (2018) · Heart · doi:10.1136/heartjnl-2017-312573 · Cited by 23

Hypertension associated with atrial fibrillation

Aronow, W. S. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.10.33 · Cited by 21

Predictors of incident atrial fibrillation and influence of medications: a retrospective case–control study

Hodgkinson, J., Taylor, C. J., & Hobbs, R. F. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x578034 · Cited by 21

Treatment of Long-Lasting Persistent Atrial Fibrillation Using Minimally Invasive Surgery Combined With Irbesartan

Wang, J., Li, Y., Shi, J., Han, J., Cui, Y., Luo, T., & Xu, M. (2011) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2010.11.063 · Cited by 20

EURASIAN CLINICAL RECOMMENDATIONS ON DIAGNOSIS AND TREATMENT OF ATRIAL FIBRILLATION

Sp, G., Панченко, Е. П., Станиславовна, К. Е., Laiovich, L. I., Maykov, E. B., Mironov, N. Y., & Shakhmatova, O. O. (2019) · Eurasian heart journal · doi:10.38109/2225-1685-2019-4-4-85 · Cited by 21

Clinical U pdate on the M anagement of A trial F ibrillation

Danelich, I. M., Reed, B. N., Hollis, I. B., Cook, A. M., & Rodgers, J. E. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1217 · Cited by 21

Review: Beyond the Guidelines: New and Novel Agents for the Prevention of Atrial Fibrillation After Cardiothoracic Surgery

Reinhart, K. M., Baker, W. L., & Siv, M. L.-W. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410378120 · Cited by 19

Inflammation pathways as therapeutic targets in angiotensin II induced atrial fibrillation

Hou, A., Shi, D., Huang, H., Liu, Y., & Zhang, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1515864 · Cited by 16

Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation

Zografos, T. A., & Katritsis, D. G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02832.x · Cited by 15

Manejo de los pacientes con fibrilación auricular en los servicios de urgencias hospitalarios (actualización 2012)

Martı́n, A., Lozano, I. F., Puig, B. C.-V., Tercedor, L., del Arco, C., Ynsaurriaga, F. A., Méndez, C. S., & Girbau, L. M. (2012) · Emergencias · Cited by 14

Atrial Fibrillation and Hypertension: “Quo Vadis”

Kwon, Y., Walker, M., Patel, P., Kwon, O., Koene, R. J., & Duprez, D. A. (2022) · Current Hypertension Reviews · doi:10.2174/1573402118666220112122403 · Cited by 15

Use of Angiotensin‐Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Therapy to Reduce Cardiovascular Events in High‐Risk Patients: Part 1

Bommer, W. J. (2008) · Preventive Cardiology · doi:10.1111/j.1751-7141.2008.08435.x · Cited by 13

Upstream Effect for Atrial Fibrillation: Still a Dilemma?

Calò, L., Martino, A., Sciarra, L., Ciccaglioni, A., Ruvo, E. D., Luca, L. D., Sette, A., Giunta, G., Lioy, E., & Fedele, F. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02942.x · Cited by 13

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis

Lin, T., Chiang, J., Liao, M., Tsai, C., Hwang, J., Chiang, F., Lin, J.-L., & Lin, L. (2015) · Scientific Reports · doi:10.1038/srep17731 · Cited by 12

Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation

Yu, Z., Zhang, D., Ji, Q.-H., & Yi, F. (2021) · Medicine · doi:10.1097/md.0000000000025559 · Cited by 12

Blood pressure in patients with atrial fibrillation: part 2—treatment

Cohen, D. L., & Townsend, R. R. (2016) · Journal of Clinical Hypertension · doi:10.1111/jch.12939 · Cited by 10

Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit

Anderson, S. G., Shoaib, A., Myint, P. K., Cleland, J. G. F., Hardman, S. M. C., McDonagh, T. A., Dargie, H., Keavney, B. D., Garratt, C. J., & Mamas, M. A. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01463-5 · Cited by 10

Atrial Fibrillation and the Renin-Angiotensin-Aldosterone System

Perlini, S., Belluzzi, F., Salinaro, F., & Musc, F. (2013) · InTech eBooks · doi:10.5772/53917 · Cited by 9

Atrial fibrillation and arterial hypertension

Баранова, Е. И. (2011) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2011--4- · Cited by 9

Adjuvant Therapy for Atrial Fibrillation

Mohammed, K., Kowey, P. R., & Musco, S. (2009) · Future Cardiology · doi:10.2217/fca.09.57 · Cited by 8

Upstream Therapy for Atrial Fibrillation in Heart Failure

Goette, A. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.010 · Cited by 8

Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?

Solun, B., Marcoviciu, D., & Dicker, D. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.07.001 · Cited by 8

Eurasian clinical guidelines for the diagnosis and treatment of atrial fibrillation in adult patients (2025)

Sp, G., Панченко, Е. П., Mironov, N. Y., Михайловна, Б. М., Gagloeva, D. A., Elfimova, E. M., Станиславовна, К. Е., Laiovich, L. I., Litvin, A. Y., Maykov, E. B., et al. (2025) · Eurasian heart journal · doi:10.38109/2225-1685-2025-3-6-77 · Cited by 8

Focus on renin–angiotensin system modulation and atrial fibrillation control after GISSI AF results

Durin, O., Pedrinazzi, C., & Inama, G. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32833cdd6f · Cited by 7

Elevations in serum creatinine with RAAS blockade: why isnʼt it a sign of kidney injury?

Ryan, M. J., & Tuttle, K. R. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e32831daeff · Cited by 6

A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study

Vincenti, A., Rota, M., Spinelli, M., Corciulo, M., Ceglia, S. D., Rovaris, G., Antolini, L., & Genovesi, S. (2011) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2011.08.005 · Cited by 6

Renin-Angiotensin System and AtrialFibrillation:Understanding the Connection.

Disertori, M., & Quintarelli, S. (2011) · Europe PMC (PubMed Central) · doi:10.4022/jafib.398 · Cited by 5

Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2

Rivard, L., Samuel, M., Fortier, A., Guertin, M., Khairy, P., Roy, D., Talajic, M. R., & Tardif, J. (2021) · CJC Open · doi:10.1016/j.cjco.2021.04.014 · Cited by 4

Primary Prevention of Atrial Fibrillation where are we in 2012?

Imazio, M. (2012) · Europe PMC (PubMed Central) · doi:10.4022/jafib.608 · Cited by 4

Nebivolol and quinapril reduce p-wave duration and dispersion in hypertensive patients.

Korkmaz, H., Önalan, O., Akbulut, M., & Özbay, Y. (2009) · PubMed Central · Cited by 4

New insight into the association among atrial fibrillation, electrophysiological remodeling, and the ACE insertion/deletion polymorphism—Toward a more patient-tailored therapy?

van den Berg, M. P., & Gelder, I. C. V. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.06.008 · Cited by 4

Meta-analysis of renin angiotensin aldosterone modulators mitigating atrial fibrillation risk in hypertensive patients

Mahadevan, A., Garikipati, S., Vanani, S., Sundaram, D. M., Thompson‐Edwards, A., Reyaz, N., Babu, K., Rajarajan, S., Dhavapalani, D., Anand, D. P., et al. (2024) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2024.07.016 · Cited by 3

The Efficacy and Tolerability of Commonly Used Agents to Prevent Recurrence of Atrial Fibrillation After Successful Cardioversion

Gonna, H., & Gallagher, M. M. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0064-5 · Cited by 4

2018 Korean Heart Rhythm Society Guidelines for Detection and Management of Risk Factors and Concomitant Cardiovascular Diseases in Korean Patients with Atrial Fibrillation

Lee, S.-R., Lee, Y.-S., Lim, W., Kim, T.-H., Cha, M., Lee, J., Baek, Y., Lim, H., Joung, B., Kim, J., et al. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.4.324 · Cited by 2

Atrial Fibrillation: Upstream Therapies

Kourliouros, A., Savelieva, I., Jahangiri, M., & Camm, A. J. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch36 · Cited by 2

ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery

Knobloch, K., Gohritz, A., Spies, M., & Vogt, P. M. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2007.174698a · Cited by 2

Cardiología (ESC) Desarrolladas con la contribución especial de European Heart Rhythm Association (EHRA) Aprobado por European Association for Cardio-Thoracic Surgery (EACTS)

Camm, A. J., Kirchhof, P. F., Ernst, S., Gelder, I. C. V., Hindricks, G., Heidbüchel, H., Colonna, P., Goette, A., Hohloser, S. H., Kolh, P. H., et al. (2010) · Cited by 2

Advances in the management of atrial fibrillation

Li, A. C., & Behr, E. R. (2012) · Clinical Medicine · doi:10.7861/clinmedicine.12-6-544 · Cited by 1

Advances in the Treatment of Atrial Fibrillation Complicated with Hypertension by Traditional Chinese Medicine and Western Medicine

杨, 胜. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.14112839 · Cited by 1

Atrial fibrillation in diabetes: A cause for concern?

Szwejkowski, B. R., Rekhraj, S., Morris, A. D., & Struthers, A. D. (2012) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2012.24059 · Cited by 1

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy

Khan, N. A., Hemmelgarn, B. R., Herman, R. J., Bell, C. M., Mahon, J. L., Leiter, L. A., Rabkin, S. W., Hill, M. D., Padwal, R. S., Touyz, R. M., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70492-1 · Cited by 2

Prévalence de la fibrillation atriale non valvulaire et de l´accident vasculaire cérébral ischémique et facteurs associés à la fibrillation atriale non valvulaire chez les patients hypertendus: étude observationnelle à propos de 2887 patients

Bahloul, A., Bouattour, N., Triki, F., Hammami, R., Charfeddine, S., Ellouze, T., Mhiri, C., Abid, L., & Kammoun, S. (2021) · Pan African Medical Journal · doi:10.11604/pamj.2021.38.31.25569 · Cited by 1

Atrial Fibrillation and Heart Failure in the Aging Population

Kazemian, P., & Jugdutt, B. I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_5

International differences in the clinical effectiveness of medical interventions: a study using “panoramic” meta-analysis

Hartley, L. (2012) · University of Birmingham Institutional Research Archive (University of Birmingham)

1 Hypertensie: definitie en achtergronden

van den Born, B. H., Potkamp, J. J., & van Montfrans, G. A. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7372-7_1

Upstream Therapy in the Treatment of Atrial Fibrillation

Băicuş, C. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5475-4_4

Valsartan and Amlodipine: Safety and Efficacy in Stroke Prevention

Ichihara, K. B. A. A. (2010) · Clinical Medicine Reviews in Vascular Health · doi:10.4137/cmrvh.s5204

ACE inhibitors as antifibrotic agents in atrial fibrillation: potential relevance in cardiac surgery

Raja, S. G. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2007.174698a1

A multistudy analysis investigating systematic differences in cardiovascular trial results between Europe and Asia

Hartley, L., Girling, A. J., Bowater, R. J., & Lilford, R. J. (2014) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2013-203646

Treatment with renin-angiotensin-aldosterone system inhibitors and the decrease in inflammatory markers in paroxysmal atrial fibrillation.

Roşianu, Ş. H., Roşianu, A., Aldica, M., Capalneanu, R., & Buzoianu, A. D. (2013)

Plasma Angiotensin Converting Enzyme Level and Permanent Atrial Fibrillation with Mitral Valvular Disease

Qian, Y., Hanzhang, S., Luo, T.-X., Dongmin, W., Xiang, B., Jun, M., & Xiao, X. (2008) · Zhongguo xiong-xin xueguan waike linchuang zazhi

Welche kardiale Diagnostik braucht Ihr Hypertoniker?

Ukena, C., Mahfoud, F., & Böhm, M. (2014) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-014-3214-4

REVIEW Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation

Zografos, T. A., Katritsis, D. G., & Ph., D. (2016)

Inhibition of the Renin-Angiotensin System for Prevention of Atrial Fibrillation

Zografos, T. A., & Katritsis, D. G. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02832.x · Cited by 15

The Role of Renin–Angiotensin System Blockade Therapy in the Prevention of Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Zhang, Y., Zhang, P., Mu, Y., Gao, M., WANG, J., Wang, Y., Su, L., & Hou, Y. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.123 · Cited by 45

Blockade of the renin–angiotensin–aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: A systematic review and meta analysis of randomized controlled trials

Khatib, R., Joseph, P., Briel, M., Yusuf, S., & Healey, J. S. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.02.009 · Cited by 126

The Impact of Suppressing the Renin‐Angiotensin System on Atrial Fibrillation

Kalus, J. S., Coleman, C. I., & White, C. M. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005283284 · Cited by 59